FDA Approves First Drug for Neuromyelitis Optica
Deborah Brauser – DISCLOSURES June 27, 2019 The US Food and Drug Administration (FDA) has approved the humanized monoclonal antibody eculizumab (Soliris, Alexion Pharmaceuticals) for the…
Categories
Latest Blog Posts
- How MS Causes Memory Loss and 5 Tips To Help With Forgetfulness
- Risks of Comorbidities With Multiple Sclerosis
- The Differences Between Heart Failure and Other Common Cardiac Conditions
- Treating Multiple Sclerosis: Are They Doing It Wrong?
- PRESS RELEASE : Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis
- video: MOBILITY AIDS and HELPFUL TOOLS
- Neuromyelitis (NMO) & MOG with MS Specialist Dr. Carraro
- Long COVID and its relationship to MS
- Reduce Your Risk from Respiratory Viruses This Holiday Season
- Smoldering MS: the real MS becomes a tractable problem
- How Much Vitamin B12 Is Too Much?
- PRESS RELEASE –
- 2024 Revisions to McDonald Diagnostic Criteria for Multiple Sclerosis: Peter Calabresi, MD
- Conquering Dizziness: Everything You Need to Know About Vestibular Symptoms, Vestibular Migraine and How to Manage
- Home Safe Home: Tips for Creating an Accessible Space
- Driving without using your feet! Disability driving with hand controls – video
- Driving with Multiple Sclerosis
- How Age Affects MS Symptoms and Progression
- How to Sleep Better When You Have Chronic Pain
- COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review